Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price rose 1.5% on Tuesday . The company traded as high as $0.47 and last traded at $0.46. Approximately 6,803,961 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 28,090,684 shares. The stock had previously closed at $0.45.
Wall Street Analysts Forecast Growth
TLRY has been the subject of several recent analyst reports. Roth Capital reiterated a "neutral" rating on shares of Tilray in a research note on Monday, April 14th. Piper Sandler cut their price target on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a report on Wednesday, April 9th.
View Our Latest Stock Report on Tilray
Tilray Stock Performance
The firm has a market cap of $445.27 million, a price-to-earnings ratio of -1.47 and a beta of 1.95. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The firm has a fifty day simple moving average of $0.52 and a two-hundred day simple moving average of $0.92.
Tilray (NASDAQ:TLRY - Get Free Report) last released its earnings results on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The company had revenue of $185.78 million during the quarter, compared to analyst estimates of $213.38 million. On average, analysts expect that Tilray Inc will post -0.2 EPS for the current year.
Institutional Investors Weigh In On Tilray
A number of large investors have recently made changes to their positions in TLRY. JPMorgan Chase & Co. lifted its position in Tilray by 32.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 432,031 shares of the company's stock worth $760,000 after acquiring an additional 105,803 shares during the period. Ameritas Advisory Services LLC purchased a new position in shares of Tilray in the fourth quarter worth about $32,000. KBC Group NV lifted its holdings in shares of Tilray by 75.9% during the fourth quarter. KBC Group NV now owns 38,332 shares of the company's stock worth $51,000 after purchasing an additional 16,539 shares during the period. Newman Dignan & Sheerar Inc. boosted its position in Tilray by 61.9% in the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after buying an additional 10,000 shares during the last quarter. Finally, CIBC Asset Management Inc boosted its position in Tilray by 11.4% in the fourth quarter. CIBC Asset Management Inc now owns 1,011,740 shares of the company's stock valued at $1,335,000 after buying an additional 103,642 shares during the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
